Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAX · BSE: 531015 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹15.01
Market cap: ₹13.18 Cr
Revenue (annual): ₹8.02 Cr
Net profit (annual): ₹0.25 Cr
P/E (TTM): 47.0×Sector 50.4×
Promoter holding: 10.46%-3.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Acquisition 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

7 Aug 2026 16:56 IST BSE

Financial Results

Venmax Drugs & Pharmaceuticals Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% QoQ

Venmax Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹2.5 Cr (+108.3% YoY) and net profit of ₹0.1 Cr for Q1 FY27.

Key figure: Net profit ₹0.1 Cr

Open full results → Read the filing ↗

14 May 2026 17:16 IST BSE

Financial Results

Venmax Drugs & Pharmaceuticals Q4 FY26 Results: Net Profit ₹0.1 Cr, Down 87.5% YoY

Venmax Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹3.9 Cr (+1200.0% YoY) and net profit of ₹0.1 Cr (-87.5% YoY) for Q4 FY26.

Key figure: Net profit ₹0.1 Cr · -87.5% YoY

Open full results → Read the filing ↗